Tamoxifen’s Dual Impact on Endometrial Cancer in Male and Female Patients
Reading Time: 2 minutesIntroduction Tamoxifen, a widely prescribed selective estrogen receptor modulator (SERM), has been a cornerstone in the treatment and prevention of breast cancer among women. However, its impact on endometrial cancer, particularly in the context of male patients, remains a subject of intense scrutiny and debate. This article delves into the complex relationship between tamoxifen and endometrial cancer, highlighting its dual... Read more »
